Fidson dominates Nigeria’s Pharma sector first-quarter 2026

Fidson is described as dominating Nigeria’s pharmaceutical sector in the first quarter of 2026. The report links rising medicine demand to population growth, urbanisation and greater healthcare awareness, providing sector context for investors tracking the company.